Excelya
Excelya is a France-headquartered, global full-service Contract Research Organization delivering clinical trial services through Full Service, FSP, and Resourcing models to biotech, pharmaceutical, and medical device sponsors across 25+ countries.
- Company typePrivate
- Founded2014
- HeadquartersBoulogne-billancourt, France
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Excelya does
Excelya is a France-headquartered, global full-service Contract Research Organization (CRO) founded in 2014 that delivers clinical research services to biotech, pharmaceutical, and medical device sponsors. The company operates through three commercial engagement models (Full Service CRO, Functional Service Provider, and Clinical Resourcing) delivered across eight Centers of Excellence (Clinical Operations, Pharmacovigilance & Safety, Data Management, eTMF Management, Statistics & Programming, Medical Affairs, Regulatory Affairs, and Quality Assurance) and six therapeutic areas (Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & RWE). Across 25+ countries and 16 offices, Excelya employs 1,000+ professionals and reports having supported more than 550 clinical trials.
The company's technology stack is built on partnerships rather than proprietary infrastructure: eTMF runs on Veeva Vault (formalized through a 2021 Veeva Services Partner relationship), and clinical data management supports three of the top five EDC platforms including Viedoc and Oracle Clinical One. Real-world evidence work is differentiated by OMOP Common Data Model expertise, enabling harmonized vocabulary mapping (SNOMED, RxNorm) and federated analytics across hundreds of millions of patient records. Excelya generated ~€70M in combined revenues in 2020 following a same-day acquisition of three European CROs (Zeincro, The Clinical Company, Koehler eClinical), scaling the workforce from a pre-deal base to 800 employees across 24 European countries.
The business model is professional services revenue billed under multi-year contracts with quote-based pricing tied to project scope and engagement model. Go-to-market is enterprise field sales supported by direct RFP submission and active participation in industry conferences (PSI, PV Europe, OCT Europe, ACDM, UBIQ). Customer evidence is anchored by a 10-year pharmacovigilance partnership with UCB and case studies spanning top-20 global pharma, biopharma, generics, and CAR-T developers. In November 2025, Eurazeo acquired a minority stake via a sponsorless leveraged buyout earmarked for growth, US expansion, AI/automation investment, and a co-founder-led management transition.
Excelya firmographics
Firmographics- Name
- Excelya
- Legal name
- EXCELYA GROUP
- Website
- https://excelya.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Excelya is a France-headquartered, global full-service Contract Research Organization delivering clinical trial services through Full Service, FSP, and Resourcing models to biotech, pharmaceutical, and medical device sponsors across 25+ countries.
- Ownership category
- akta.pro rank
Excelya industry classification
Industry- Product category
- Contract Research Organization Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where Excelya is headquartered
LocationHeadquarters
- HQ city
- Boulogne-billancourt
- HQ country
- France
- HQ region
- Europe
Offices11 records
Markets served
Excelya business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Excelya generates revenue through providing comprehensive clinical research organization services including full-service CRO, Functional Service Provider (FSP) arrangements, and clinical resourcing solutions to biotech, pharma, and medical device companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Full Service CRO Model |
| Other | Multi-year contract | Functional Service Provider (FSP) |
| Other | Multi-year contract | Clinical Resourcing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Excelya product offering
Product offeringCore offering
Excelya is a global full-service Contract Research Organization (CRO) that delivers clinical research services to biotech, pharmaceutical, and medical device organizations through three contractable engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The offering spans eight Centers of Excellence—Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance—delivered across six therapeutic specializations including Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & Real-World Evidence.
Product overview
Excelya is a global full-service Contract Research Organization (CRO) offering clinical research services through three engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The company operates through eight Centers of Excellence (Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance) and covers six therapeutic areas (Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & RWE). Excelya delivers services across 25+ countries with 1000+ experts and 16 offices, supporting Biotech, Pharma, and Medical Device organizations from early-phase through post-marketing studies.
Differentiator
Problem solved
Functional benefit
Products and services
- Full Service CRO
- Functional Service Provider (FSP)
- Clinical Resourcing
- Clinical Operations
- Pharmacovigilance & Safety
- Clinical Data Management
- Statistics & Programming
- Medical Affairs & Medical Writing
- eTMF Management
- Regulatory Affairs
- Quality Assurance
Quantifiable outcome
- 16% cost reduction achieved for clients
- +4 more outcomes
Companies that use Excelya
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Excelya technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature4 records
Excelya partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and flagship.
- Veeva SystemscorePartnership with Veeva Systems as primary eTMF provider, enabling Excelya to offer best-in-class electronic Trial Master File management services to clients using market-leading software combined with professional expertise.
- ZeincrocoreZeincro, a CRO primarily operating in Central-Eastern & Southern Europe with expertise in clinical operations, safety and medical affairs, joined Excelya Group. The acquisition expanded Excelya's European footprint to 24 countries.
- The Clinical CompanycoreThe Clinical Company, a full-service CRO present in Belgian and Dutch markets specializing in clinical operations, joined Excelya Group to expand services in Benelux region.
- Koehler eClinicalcoreKoehler eClinical, a German specialty CRO with focus on biostatistics and data solutions including proprietary software VITESSA, joined Excelya Group to strengthen data-centric capabilities.
- UCBflagship10-year pharmacovigilance partnership between Excelya and UCB, evolved from operational service delivery to a mature 'one team' model. Excelya provides 24 PV professionals supporting UCB locally across Europe with monthly operational meetings and proactive communication.
Scale indicators14 records
Recent moves8 records
Expansion highlights6 records
Excelya competitors and assessment
Company assessmentEmerging players
- KCR: European-based CRO with overlapping therapeutic areas (oncology, rare disease) and similar mid-size positioning; competes with Excelya for European biotech and mid-pharma RFPs.
- TFS HealthScience: European-headquartered mid-size CRO offering full-service and FSP solutions across multiple therapeutic areas; another regional peer overlapping with Excelya's geographic and service footprint.
Direct peers
- Medpace: Mid-to-large US-headquartered full-service CRO with strong therapeutic-area focus (oncology, rare disease); the closest pure-play comparable in size, operating model, and TA emphasis to Excelya.
- Parexel: Global full-service CRO with deep oncology, rare disease, and clinical technology offerings; competes with Excelya for mid-sized pharma and biotech trial awards across all phases.
- Fortrea (formerly Labcorp Drug Development): Full-service clinical CRO spun out of Labcorp offering end-to-end Phase I–IV services plus FSP; directly competes in the same therapeutic and resourcing categories as Excelya.
- Syneos Health: Full-service biopharmaceutical solutions organization combining CRO services with commercial capabilities; directly competes with Excelya in clinical operations and FSP engagements.
- ICON plc: Global full-service CRO offering Phase I–IV clinical trial services, FSP, and lab services to biopharma; directly competes with Excelya across Full Service, FSP, and resourcing engagements.
- Worldwide Clinical Trials: Mid-size global CRO focused on complex therapeutic areas including CNS, oncology, and rare disease; closest size-and-TA comparable to Excelya for sponsor benchmarking.
Broad incumbents
- Charles River Laboratories: Broader life sciences services platform spanning early-stage CRO, discovery, and safety assessment; overlaps with Excelya in clinical and safety/pharmacovigilance services as part of a wider portfolio.
- IQVIA: Largest global CRO with deep technology and data assets (including real-world evidence); competes head-to-head with Excelya on large sponsor RFPs while also defining the Tier-1 benchmark Excelya differentiates against.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Excelya social profiles
Digital presenceExcelya compliance and trust
Trust signalCompliance5 records
Excelya financial estimates
Financial estimateRevenue estimate
Valuation estimate
Excelya leadership team
Management profileNumber of profiles
Profiles13 records
Excelya subsidiaries and ownership
Company hierarchySubsidiaries3 records
Excelya funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Excelya M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Excelya
What does Excelya do?
Excelya is a global full-service Contract Research Organization (CRO) that delivers clinical research services to biotech, pharmaceutical, and medical device organizations through three contractable engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The offering spans eight Centers of Excellence—Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance—delivered across six therapeutic specializations including Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & Real-World Evidence.
Is Excelya a public or private company?
Excelya is a private company. It is classified as private equity controlled and is currently operating.
When was Excelya founded?
Excelya was founded in 2014. It employs 501 to 1,000 people.
Where is Excelya based?
Excelya is headquartered in Boulogne-billancourt, France, in the Europe region.
How does Excelya make money?
One revenue line is on record: clinical Research Services.
Who are Excelya's main competitors?
Emerging players on record are KCR and TFS HealthScience. Direct peers are Medpace, Parexel, Fortrea (formerly Labcorp Drug Development), Syneos Health, ICON plc and Worldwide Clinical Trials. Broad incumbents are Charles River Laboratories and IQVIA.
Does Excelya have an API?
No public API is recorded for Excelya.
What industry is Excelya in?
Excelya's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8000.